La Rosa Holdings Corp (LRHC) announced stellar Q3 2024 results, boasting a 188% year-over-year revenue surge to $19.6 million, driven by strategic acquisitions and fee increases. The company anticipates a $100 million annualized revenue run rate by year-end and profitability in 2025.
Becton, Dickinson and Company (BDX) exceeded analysts’ expectations for fourth-quarter earnings and sales, driven by robust growth in its Medical segment and a strategic focus on higher-growth areas. The company also announced a dividend increase and provided optimistic guidance for fiscal year 2025, anticipating strong revenue growth fueled by new innovations and acquisitions.
AbbVie exceeded third-quarter earnings expectations, boosted its 2024 guidance, and announced the acquisition of Aliada Therapeutics for $1.4 billion. The company’s strong performance was driven by its immunology and neuroscience portfolios, with key products like Skyrizi and Rinvoq showing significant growth. AbbVie also increased its dividend and expects continued success in the coming year.
Lithia Motors, Inc. (LAD) exceeded analysts’ expectations for third-quarter earnings, driven by strong performance in its retail and aftersales segments. The company also expanded its presence in the Southeast through strategic acquisitions, boosting its annualized revenue from acquisitions to over $5.9 billion. Despite missing revenue expectations, Lithia’s solid earnings and expansionary moves have fueled a positive market reaction, sending its shares up in premarket trading.
DaVita, a leading provider of dialysis services, has seen its stock price climb 47.3% this year, fueled by strategic acquisitions, strong second-quarter performance, and a focus on patient-centric care. The company is expanding its global reach, acquiring dialysis centers, and raising its earnings forecast for 2024, signaling a positive outlook.
Abbott Laboratories’ strong MedTech portfolio, driven by a robust product pipeline and strategic acquisitions, is attracting attention from analysts. Oppenheimer analyst Suraj Kalia initiated coverage with an ‘Outperform’ rating and price target of $130, citing the company’s impressive growth potential and market advantages.
This article highlights five stocks that are likely to attract investor attention on Friday, based on their recent earnings reports, dividend announcements, acquisitions, and stock splits. From Apogee Enterprises’ anticipated earnings to Smart Sand’s special dividend, investors will be keeping an eye on these developments.
La Rosa Holdings Corp. (LRHC) has restructured its debt with a noteholder, reducing debt by 9.5% and gaining flexibility for expansion. The company plans to acquire more businesses using stock, targeting $100 million in annual revenue by the end of 2024 and profitability in 2025.
First National Realty Partners (FNRP) has hired Stuart Brackenridge as Vice President of Acquisitions, leveraging his extensive experience in grocery-anchored shopping centers to further FNRP’s expansion in this sector. Brackenridge’s expertise will be instrumental in sourcing and acquiring prime retail assets, aligning with FNRP’s investment strategy focused on necessity-based properties.
Xylem Inc. (XYL), a leading provider of water solutions, is well-positioned for continued growth thanks to strong performance across its business segments and strategic acquisitions. The company’s commitment to rewarding shareholders through dividends and buybacks adds to its appeal. However, challenges like segmental weakness in the Applied Water segment due to economic slowdown and rising costs need to be considered.
